ABSTRACT. The Delta/Serrate-Notch pathway is involved in intercellular signaling that controls cell fate during the development of invertebrates and vertebrates. Delta is a prototype of Notch ligands and has been studied extensively in Drosophila. In higher vertebrates, four Delta/Serrate homologues and four Notch homologues have been identified. Recent studies showed that the murine Delta homologue, mDelta1, is essential in early embryogenesis. The biological activity of mammalian Delta and its roles in cellular differentiation, however, have remained unclear. In this study, we first surveyed expression of mDelta1 in the adult mouse and found it to be present in a wide range of tissues. For testing biological activity of mDelta1, we expressed a mDelta1 full-length cDNA in L cells using a eukaryotic expression vector. Effects of mDelta1 on cellular differentiation were examined in two independent systems, featuring C2C12 myogenic differentiation and multipotent murine bone marrow cell differentiation. Inhibition of the former was observed with mDelta1 expression on L cells, associated with suppression of myogenin, a myogenic transcription factor. Expression of mDelta1 in conjunction with GM-CSF promoted differentiation of bone marrow cells to myeloid dendritic cells at the expense of other lineages. Although the effects of mDelta1 on two differentiation systems appeared opposing, as inhibition occurring in one and induction in the other, this can be understood by the unifying concept of generation of diverse cell types from equivalent progenitors. Thus, the present study provided evidence that mammalian Delta participates in intercellular signaling, determining the cell fate in a wide variety of tissues.
Delta and Serrate and their receptor, Notch, are highly conserved membrane proteins in invertebrates and vertebrates, thought to play key roles in cell fate decisions during development Greenwald, 1998; Kimble and Simpson, 1997; Lewis, 1998; Milner and Bigas, 1999; Weinmaster, 1998) . Genetic and molecular studies have shown that Delta/Serrate ligands expressed on the surfaces of cells interact with and activate Notch receptors on neighboring cells. Activated Notch then translocates into nucleus and promotes the expression of sets of genes that inhibit or induce cellular differentiation. In equipotent cells, the Delta/Serrate-Notch mediates signals to effect so-called lateral inhibition in which a limited number of cells adopt the specific cell fate whereas adjacent cells are inhibited from differentiation. Delta/ Serrate-Notch interactions also occur among heterotypic or multipotent cell types with inductive signaling that permits the establishment of demarcated boundaries between cell types. Through both lateral inhibition and inductive signaling, Delta/Serrate-Notch contributes to the generation of distinct cell lineages from initially equivalent cells. Two distinct Notch ligands, Delta and Serrate, have been identified in Drosophila melanogaster Greenwald, 1998; Kimble and Simpson, 1997) and several homologues are now known in other species, including Caenorhabditis elegans (Greenwald, 1998; Kimble and Simpson, 1997) , Xenopus laevis Jen et al., 1997) , the chick (Hayashi et al., 1996; Henrique et al., 1995; Myat et al., 1996) , mouse (Bettenhausen et al., 1995; Dunwoodie et al., 1997; Jiang et al., 1998; Luo et al., 1997; Mitsiadis et al., 1997; Sidow et al., 1997) , rat (Lindsell et al., 1995; Shawber et al., 1996) and man (Gray et al., 1999; Li et al., 1998; Luo et al., 1997) . Delta, Serrate and their homologues share a socalled DSL (Delta/Serrate/Lag-2) domain and epidermal growth factor (EGF)-like tandem repeats in the extracellular region. Both the DSL domain and the EGF-like repeats are required for interaction with Notch receptors. Structural differences between Delta and Serrate exist in the extracellular and cytoplasmic domains. In the extracellular domain, mammalian Delta homologues have 8 EGF-like repeats but lack a cysteine-rich region, while Serrate homologues have 16 EGF-like repeats and a cysteine-rich region. It has been speculated that Delta and Serrate have overlapping but distinct functions. Spatial and temporal differences in their expression during fruit fly development have also been noted (Doherty et al., 1996; Muskavitch, 1994) . In higher vertebrates, Jagged, Serrate homologues, have been extensively investigated. Jagged1 is expressed in various human adult tissues (Li et al., 1998) and in rat embryos (Lindsell et al., 1995) , and Jagged2 is expressed in mouse embryos and adult tissues (Luo et al., 1997; Shawber et al., 1996) . hJagged1, hJagged2 and rJagged1 expressed in fibroblasts were found to inhibit terminal differentiation of murine C2C12 myoblasts (Lindsell et al., 1995; Luo et al., 1997) . hJagged1 expressed on HS-27a human stromal cells inhibits G-CSF-induced differentiation of murine 32D myeloid progenitor cells manipulated to express mNotch-1 (Li et al., 1998) . hJagged1 transfected in 3T3-cells also promotes proliferation of murine marrow primitive precursor cells (Varnum-Finney et al., 1998) .
In contrast to Jagged, only limited information is available for the functions of mammalian Delta1. Bettenhausen et al. showed the mouse Delta homologue, mDelta1 (Dll1), to be expressed transiently between day 7 and 12.5 of embryonic development but down-regulated by day 15.5 with expression in the adult restricted to the lung and heart (Bettenhausen et al., 1995) . Mouse embryos deficient for mDelta1 die around 12 days postcoitum (dpc) with severe patterning defects in the paraxial mesoderm where mDelta1 normally is expressed (de Angelis et al., 1997) . The expression pattern of mDelta1 suggests that mDelta1 is involved in the development of neural tubes and somites (Bettenhausen et al., 1995; de Angelis et al., 1997) . Because of embryonic lethality of mDelta1 deficient mice, its roles in cellular differentiation and development of adult mice remain unclear. Recently, and during the course of this study, it was found that mammalian Delta inhibits differentiation of C2C12 cells (Kuroda et al., 1999) . In the present study, the expression of mDelta1 in adult mice was therefore re-examined and found to be present in various tissues including lung, brain, kidney, heart, muscle, spleen and lymph nodes. To determine the biological effects of mDelta1 on cell differentiation, a full-length mDelta1 cDNA was isolated and transfected into L cells. The influence of mDelta1 expressed on L cells was then examined in two independent systems, featuring C2C12 myogenic differentiation and multipotent murine bone marrow cell differentiation.
Materials and Methods

DNA and RNA isolation
Genomic DNA was isolated from parental and transfected L cells by a proteinase K/SDS method (Blin and Stafford, 1976) . Total RNA was isolated from L cells, transfected L cells, C2C12 cells and various tissues of C3H/He mice by a guanidine thiocyanate/ CsCl method (Chirgwin et al., 1979) .
Southern blot analysis and densitometric analysis
Aliquots of 12 µg DNA digested with restriction enzymes were separated by electrophoresis in 0.7% agarose gels, and transferred to nitrocellulose membranes (Schleicher & Schuell, Dassel, Germany) . A full-length mDelta1 cDNA was labeled with 32 P using a Random Primed DNA Labeling Kit (Boehringer Mannheim, Mannheim, Germany) and used as a probe for hybridization. Intensity of hybridizing bands was measured by densitometric analysis using ATTO Densitograph software (Atto Inc., Tokyo, Japan).
Northern blot analysis
Aliquots of 10 µg total RNA were separated by electrophoresis in 1% agarose gels containing 2.2 M formaldehyde, and transferred to nitrocellulose membranes (Lehrach et al., 1977) . A full-length mDelta1 cDNA and a full-length myogenin cDNA (Wright et al., 1989 ; a gift of Dr. Harold Weintraub, Fred Hutchinson Cancer Center, Seattle, WA, USA) were labeled with 32 P and used as probes for hybridization, carried out in the presence of 50% formamide at 45°C for 16 hours. The membranes were then washed three times with 2×SSC/0.2% SDS for 15 min each followed by twice with 0.2×SSC/0.2% SDS at 45°C for 15 min each.
RT-PCR analysis for expression of mDelta1, mNotch-1, 2, 3, 4 and β-actin
The forward and reverse primers for PCR amplification were designed to produce the following fragments: mDelta1 (Genbank Accession Number X80903; nucleotide position 596 to 1008), mNotch-1 (Z11886; 4452 to 5218), mNotch-2 (D32210; 4881 to 5440), mNotch-3 (X74760; 4831 to 5240), mNotch-4 (U43691; 4061 to 4708), and β-actin (X03672; 505 to 942). Five µg total RNA from various tissues was reverse transcribed and amplified through 30 cycles (20 cycles in the case of β-actin). Amplified products were separated by electrophoresis in 1.2% agarose gels and visualized by ethidium bromide staining.
Eukaryotic expression vector
A stable eukaryotic expression vector, pCXN (Niwa et al., 1991) , the gift of Dr. Jun-ichi Miyazaki at Osaka University School of Medicine (Osaka, Japan), has a mutant neomycin phosphotransferase II (neo) gene driven by a HSV tk promoter. Due to the mutation in neo and a weak tk promoter, pCXN confers only marginal resistance to neomycin, allowing selection of transfectants with a high copy number of pCXN in the presence of a high concentration of neomycin. cDNA can be cloned at the EcoRI or XhoI sites of the rabbit β-globin gene 3 flanking sequence which contains a Poly-A signal. Transcription of inserted cDNA is driven by a cytomegalovirus immediate early (CMV-IE) enhancer and a chicken β-actin promoter.
Preparation of expression vectors containing mDelta1 constructs
Based on the published mDelta1 sequence (Bettenhausen et al., 1995; Genbank Accession Number X80903) , four pairs of polymerase chain reaction (PCR) primers specific for mDelta1 were designed to obtain full-length mDelta1 cDNA (1-2,187). Fragment 1: 5 1- 30, 3 1008-989; Fragment 2: 5 596-615, 3 1630 Fragment 2: 5 596-615, 3 -1605 Fragment 3: 5 1321 Fragment 3: 5 -1346 Fragment 3: 5 , 3 2100 Fragment 3: 5 -2081 and Fragment 4: 5 1805 and Fragment 4: 5 -1824 and Fragment 4: 5 , 3 2187 and Fragment 4: 5 -2168 . Samples of 10 µg total RNA isolated from 18.5 dpc embryonic murine brain were reverse transcribed using Superscript II reverse transcriptase (RT) (Life Technology, Rockville, MD, USA) with random primers (Boehringer Mannheim). The 1st strand cDNA was amplified through 30 cycles at 94°C for 1 min, 58°C for 2 min and 72°C for 2 min in PCR buffer (Boehringer Mannheim) with Taq DNA polymerase (Boehringer Mannheim), using a Program Temp Control System PC-800 (ASTEC Co. Ltd., Fukuoka, Japan). Four RT-PCR products were digested with appropriate restriction enzymes and ligated to produce a full-length mDelta1 cDNA. Sequencing confirmed its identity. To express mDelta1 in mammalian cell lines, the full-length mDelta1 cDNA was inserted into pCXN by adding EcoRI-linkers or modifying EcoRI-termini of pCXN to blunt ends. Sense or anti-sense orientation of mDelta1 in pCXN was determined by restriction enzyme analysis.
Transfection of mDelta1 into L cells
Murine fibroblast L cells (Wigler et al., 1977) were cultured in Iscove's Dulbecco's modified Eagle medium (I-DMEM, Life Technology) containing 7% fetal bovine serum (FBS) at 37°C in 5% CO2. DNA transfection into murine L cells was performed using a calcium phosphate co-precipitation method (Wigler et al., 1977) . Transfected L cells were selected in the presence of the neomycin derivative G418 (Geneticin, 1,200 µg/ml, Life Technology). A total of 26 colonies originating from mDelta1 transfected single cells were isolated and established as cell lines, 13 with mDelta1 ends modified by EcoRI-linker attachment, and the remaining 13 with blunt ends. Nine of the 13 clones in each group have the sense orientation of mDelta1, while the other four the anti-sense orientation.
Cell labeling with fluorescent probe
In order to distinguish myoblast C2C12 cells (Yaffe and Saxel, 1977) from parental or transfected L cells, they were labeled with the PKH2 fluorescent probe (Zynaxis Cell Science, Malvern, PA, USA), according to the manufacture's protocol. Briefly, 1×10
6 of C2C12 cells were washed in phosphate-buffered saline and resuspended in the 1 ml of supplied diluent A. Then 50 µl of 40 µM PKH-2 dye was added. After 5 min incubation at room temperature, 1 ml of I-DMEM with 7% FBS was added, and then 2 ml of FBS was slowly introduced from the underlayer to stop the labeling reaction. Labeled C2C12 cells were washed three times with I-DMEM, and used for the differentiation experiments.
Myogenic differentiation experiments
L cells transfected with sense or anti-sense mDelta1 (5×10 6 cells in 100 mm culture dish) were lethally irradiated with 4,000 rad by Hitachi MBR-1520R (Hitachi, Tokyo, Japan). C2C12 cells (8×10 5 ) labeled with PKH2 dye were plated on irradiated transfectants and cultured for 1 day in I-DMEM with 7% FBS at 37°C in 5% CO2. The culture medium was changed to FBS-free I-DMEM for the induction of myogenic differentiation (Kopan et al., 1994) . C2C12 cells were further cultured for additional 2 days and the morphological changes were examined under fluorescence and phase-contrast microscopes (Nikon, Tokyo, Japan).
Bone marrow cultures on mDelta1 transfected L cells
1×10 5 L cells transfected with sense or anti-sense mDelta1 were plated in 6-well plates (Becton Dickinson Labware, Franklin Lakes, NJ, USA), cultured for 3 days and then lethally irradiated with 4,000 rad by Hitachi MBR-1520R. Tg.H-2K b -1 mice (Hamasima et al., 1989 ) at 4-6 weeks of age were used as a source of bone marrow cells in order to distinguish them from transfected L cells (H-2K k , D k ). Induction of dendritic cells from bone marrow cells was performed as described previously (Inaba et al., 1992) with a few minor modifications. Briefly, Thy-1 + MHC Class II + B220 + cells were removed before culturing with L cells by the panning method (Wysocki and Sato, 1978) . 5×10 6 cells were cultured on the transfected L cells in 6-well plates with 5 ml of RPMI 1640 (Life Technology) containing 10% FBS, 1,000 U/ml recombinant mouse GM-CSF (a gift of Kirin Brewery Company, Tokyo, Japan) and 50 µM 2-mercaptoethanol (2-ME, Wako Pure Chemical Industries, Osaka, Japan) at 37°C in 5% CO2. The cultures were fed every two days by adding 2.5 ml of fresh medium with FBS, 2-ME, and recombinant mouse GM-CSF. At days 2, 4 and 6, cultured bone marrow cells were analyzed for their cell surface markers by flow cytometric analysis using a FACScan (Becton Dickinson, Mountain View, CA, USA).
Bone marrow cultures on mDelta1 transfected L cells without cell-to-cell contacts
Murine bone marrow cells were cultured in the upper compartment of cell culture inserts (0.45 µm pore size) placed on sense or antisense mDelta1 transfected L cells in the lower compartment of 6-well plates (Becton Dickinson Labware). At days 2, 4 and 6, cultured bone marrow cells were analyzed by a FACScan.
Bone marrow cultures in the conditioned medium of mDelta1 transfected L cells
Supernatant of 4-day culture medium of the sense or anti-sense mDelta1 transfected L cells was used as a conditioned medium. In the medium consisting of 50% conditioned medium, 10% FBS, 1,000 U/ml GM-CSF and 50 µM 2ME, bone marrow cells were cultured on the parental L cells as described above. At days 2, 4 and 6, cultured bone marrow cells were analyzed by a FACScan.
Antibodies
The following mAbs were used: biotin-conjugated hamster mAb against CD11c (Huleatt and Lefrançois, 1995) (PharMingen, San Diego, CA, USA), FITC-conjugated rat mAbs against CD11b (Springer et al., 1978) 
Cell death of cultured bone marrow cells
Cultured bone marrow cells were stained with annexin V and propidium iodide (Vermes et al., 1995) according to the manufactures protocol (Medical & Biological Labs. Co., Nagoya, Japan) and followed by FACScan analysis.
Results
Expression of mDelta1 in the mouse
Expression of mDelta1 in the adult mouse was examined by Northern blot analysis using a full-length mDelta1 cDNA as the probe. Hybridizing transcripts were detected not only in the lung and heart but also in the brain, kidney, muscle, spleen and lymph nodes (Fig. 1A) . The transcript was 3.8 kb in size as reported in the mouse embryo (Bettenhausen et al., 1995) and different from transcripts of other members of Delta/Serrate family of the mouse, 2.2 and 5.0 kb for Dll3 (Dunwoodie et al., 1997; Kusumi et al., 1998) , 5.0 kb for mSerrate-2 (mJagged2) (Luo et al., 1997) and 7.2 kb for mSerrate-1 (mJagged1) (Matsubayashi et al., unpublished data) . Although the amounts of mDelta1 transcripts in testis, bone marrow, thymus and liver were below the detection level by northern blot analysis, mDelta1 RNA was detected by RT-PCR analysis in all the tissues tested (Fig. 1B) . The previous study by Bettenhausen et al. showed mDelta1 transcripts to be present in embryos from 7 to 12.5 dpc, but absent at 15.5 dpc (Bettenhausen et al., 1995) . They also showed that in the adult mouse mDelta1 transcripts were present only in the lung and heart, but not in other tissues. In human, H-Delta-1 expression is limited to adult heart, pancreas, brain and muscle (Gray et al., 1999) . Thus, the tissue distribution of mDelta1 in the adult mouse seems slightly different from that of H-Delta-1. The present study, however, showed mDelta1 to be expressed in a wider range of tissues than originally reported, suggesting that it participates in development and differentiation at many sites.
Establishment of mDelta1 transfected L cell lines
Based on genetic studies of the fruit fly and on structural similarities among Drosophila Delta and mammalian Serrate homologues, mammalian Delta has been speculated to be also involved in cell fate decisions without proof of such activity. To test whether this actually the case with mDelta1, a full-length cDNA (2,187 bp) was obtained by RT-PCR of RNA from the 18.5 dpc embryonic brain with four sets of mDelta1 specific primers and by ligation of the four RT-PCR products (see Materials and Methods). After confirming by sequencing that the cDNA was indeed mDelta1, it was inserted into a eukaryotic expression vector, pCXN, in which transcription of cDNA is driven by a CMV-IE enhancer and a chicken β-actin promoter. Plasmids with mDelta1 in the sense or anti-sense orientation in relation to the enhancer and promoter were prepared and transfected into L cells by calcium phosphate precipitation. After a few weeks of selection in the culture medium containing 1,200 µg/ml G418, over a dozen L cell lines transfected with sense or anti-sense mDelta1 were established. Southern blot and the densitometric analysis of hybridizing fragments showed the transfectants to contain 3 to 25 times the copies of endogenous mDelta1 DNA present in the parental L cells (data not shown). Abundant expression of sense and anti-sense mDelta1 mRNA in transfectants was confirmed by Northern blotting (Fig. 2A) . The amounts were so large that it was difficult to make precise comparisons but rough estimation demonstrated it was several hundredfold more than those in the lung, which expresses the largest amounts of mDelta1 among normal adult tissues (Fig. 2B) . L cell transfectants with high expression of sense or anti-sense mDelta1 ( * in Fig. 2A) were selected for the differentiation experiments. The size of the sense mDelta1 transcripts was 2.8 kb and slightly smaller than that of anti-sense mDelta1. The reason for this size difference was unclear and remains to be determined.
Suppression of myogenic differentiation by mDelta1
The effect of mDelta1 on cellular differentiation was examined in the C2C12 murine myogenic system (Kopan et al., 1994; Weintraub, 1993) . C2C12 cells were cultured on L cells expressing large amounts of sense or anti-sense mDelta1. For ease of observation, C2C12 cells were prelabeled with a fluorescent dye. When cultured alone, C2C12 cells after serum starvation change their morphology from undifferentiated growing myoblasts (Fig. 3A) to differentiated myocytes, aligned and fused with each other to form networks of multinucleated myotubes (Fig. 3B) . On sense mDelta1 transfected L cells, C2C12 cells showed a morphology similar to the undifferentiated myoblasts even after the induction of differentiation (Fig. 3C) . In contrast, on L cells transfected with anti-sense mDelta1, C2C12 myoblasts differentiated to myocytes (Fig. 3D) .
To confirm the inhibition of cell differentiation by mDelta1, the expression of a muscle-specific gene was examined by Northern blot analysis. It has been reported that most myoblasts in culture express MyoD and Myf-5 myogenic transcription factors, but turn on the other transcription factor, myogenin and muscle structural genes only when induced to differentiate (Weintraub, 1993) . As shown in Figure 4 , C2C12 cells in the exponential growth phase did not express myogenin (lane 1), and after induction of differentiation by serum starvation up-regulation was observed (lane 2), correlating well with morphological change. C2C12 cells on anti-sense mDelta1 transfectants also expressed myogenin after being induced to differentiate (Fig. 4, lanes 7, 8) , but this was not the case in sense mDelta1 transfected L cells (Fig. 4, lanes 3-6) . L cells transfected with mDelta1 themselves did not express myogenin (Fig. 4, lanes 9, 10) . Thus, the results indicated that mDelta1 expressed in feeder fibroblasts inhibits myogenic differentiation of C2C12 cells. These results of suppression of C2C12 differentiation by mDelta1 were in complete agreement with recently published findings (Kuroda et al., 1999) .
Accelerated differentiation of myeloid dendritic cells mediated by mDelta1
To test the influence of mDelta1 on differentiation of multipotent precursor cells, murine bone marrow cells were co-cultured with mDelta1 transfected L cells in the presence of GM-CSF. Without feeder fibroblasts, GM-CSF promotes differentiation of bone marrow progenitors along the myeloid lineage to mature dendritic cells (Inaba et al., 1992) . Myeloid lineage dendritic cells derived from bone marrow express specific cell surface markers of integrin family CD11c (α X β 2 ) and CD11b (α M β 2 ). As dendritic cells mature, they upregulate expression of both MHC Class II and CD86 (B7-2) adhesion molecules (Inaba et al., 1992; Inaba et al., 1994) . After 6 days under our culture conditions, approximately 20% were CD11c + CD11b + myeloid lineage cells and half expressed MHC class II and CD86. The majority were positive for CD11b but negative for CD11c, MHC class II or CD86, and a proportion expressed F4/80 or SER-4, suggesting they belong to another hematopoietic lineage, for example, macrophages (data not shown). As shown in Figure 5 , bone marrow cells co-cultured with mDelta1 transfected L cells in the presence of GM-CSF readily differentiated to myeloid lineage dendritic cells. On day 2, CD11c + CD11b + cells already comprised one third of the population and increased to become predominant on day 6. Furthermore, most CD11c + CD11b + cells expressed both MHC Class II and To test whether the action of mDelta1 on dendritic cell differentiation requires the cell-to-cell contacts, a microporous membrane was inserted between bone marrow cells and L cell transfectants. Without direct contact, the rate of dendritic cell differentiation was not different whether bone marrow cells were cultured with sense mDelta1 transfectants or with anti-sense mDelta1 transfectants (data not shown). The results indicated that accelerated differentiation of myeloid dendritic cells by sense mDelta1 transfected L cells was mediated by direct cell-to-cell contact, but not by a soluble protein(s) produced by the sense mDelta1 transfected L cells. To further confirm this, the conditioned medium of sense or of anti-sense mDelta1 transfected L cells was added to the culture of bone marrow cells with parental L cells. No difference in the dendritic cell differentiation was observed between the two conditioned media (data not shown), indicating that no differentiation promoting factors were produced specifically by mDelta1 transfectants. Thus, these results showed that direct interaction of mDelta1 expressing L cells with the receptor expressing bone marrow cells was necessary to promote dendritic cell differentiation.
To examine the possibility that mDelta1 influences cell survival, i.e., preferentially protects myeloid/dendritic cells from cell death or promotes cell death of other lineages, cultured bone marrow cells were examined by staining with annexin V-FITC and propidium iodide. No differences in total viable cell numbers or in the mode of cell death (apoptosis/necrosis) were observed between bone marrow cells cultured on sense mDelta1 transfected L cells and those on anti-sense mDelta1 transfected L cells (data not shown). Thus, the preferential expansion of myeloid dendritic cells is the result of direct action of mDelta1 on the differentiation rather than an indirect influence on cell death.
Expression of Notch receptors in C2C12 and bone marrow cells
In the present study, mDelta1 inhibited C2C12 myogenic differentiation or induced myeloid dendritic cell differentiation without engineered over-expression of Notch receptors, unlike in the previous report (Lindsell et al., 1995) . Thus, natural receptors for mDelta1 must exist on the cell surfaces of C2C12 and bone marrow cells. Members of the Notch family are most likely candidates, although there is a possibility that other receptor molecules may mediate signals from mDelta1. Assessment of expression of Notch family members by RT-PCR demonstrated that C2C12 cells expressed mNotch-1, mNotch-2, mNotch-3, but not mNotch-4 and that bone marrow cells expressed all four members (data not shown). We are now producing antibodies specific to mNotch-1 to allow determination of whether it is responsible for affected differentiation of C2C12 and of bone marrow cells by interacting with mDelta1.
Discussion
Our results clearly demonstrated that mDelta1 can influence the differentiation of target cells by inhibiting or promoting differentiation depending on the system. Almost all previous experiments using cultured cells have resulted in inhibition of differentiation by Delta/Serrate-Notch signaling, as we demonstrated here for the C2C12 myogenic system. During development, Delta/Serrate-Notch mediates not only lateral inhibition but also inductive signals, both of which are important to generate distinct sets of tissues and cell types from initially equivalent cells. The inductive signals of the Delta/Serrate-Notch pathway play a role in formation of demarcated tissue boundaries as in vertebrate limb development (Gaunt, 1997) and dorsal-ventral formation during fly wing margin specification (de Celis et al., 1996) . Another example of inductive signals in vivo is the increase in CD8 T cells and corresponding decrease in CD4 T cells in the T cell lineage of transgenic mice with activated mNotch1 (Robey et al., 1996) . However, no in vitro culture systems for inductive signals of Delta/SerrateNotch have been reported. The most likely explanation of the preferential differentiation of myeloid dendritic cells by mDelta1 demonstrated in this study is that while mDelta1 inhibits cellular differentiation of multipotent bone marrow cells, the targets remain sensitive to GM-CSF and differentiate to myeloid dendritic cells. This can be considered as an example of inductive signaling. Delta/Serrate-Notch effects are undoubtedly exerted in cooperation with other molecules. Molecules involved in lateral inhibition have been actively investigated Greenwald, 1998; Kimble and Simpson, 1997; Kuroda et al., 1999; Weinmaster, 1998) , while those in inductive signals have remained unresolved. Molecular dissection of effects of mDelta1 on myeloid dendritic cell differentiation from multipotent bone marrow cells in the presence of GM-CSF should yield valuable information not only on inductive signals of the Delta/Serrate-Notch pathway but also on myeloid differentiation.
In the present study, the degree of mDelta1 expression in transfected L cell clones was, however, extremely high, far above physiological levels. Derivation of mice that lack mDelta1 only in targeted tissues and generation of an antibody that inhibits activity of mDelta1 should facilitate studies on defining the physiological functions of mDelta1 in development and cellular differentiation. Similar biological activity has been described for rJagged1 (Lindsell et al., 1995) , hJagged1 and hJagged2 (Luo et al., 1997). Despite of the presence of gene products with apparently overlapping functions, mDelta1 deficient mice demonstrate embryonic lethality indicating that mDelta1 is essential for the development of vital organs or tissues (de Angelis et al., 1997) . It has been suggested that differential temporal-spatial expression of each Delta/Serrate ligand determines their specific roles in development (Doherty et al., 1996; Kimble and Simpson, 1997; Muskavitch, 1994) . Furthermore, overlapping but distinct function of each member of Notch family has been suggested by the embryonic lethality of mNotch-1 deficient mice (Swiatek et al., 1994) . Thus, differential expression of Notch receptors and variation in their affinity for Delta/Serrate ligands could also contribute to specificity of action.
We are now in the process of testing whether mDelta1 has effects on other differentiation systems. It is of particular interest to test whether hematopoietic stem cells can be maintained in a multipotential state by culturing with mDelta1 transfected L cells. It has been demonstrated that hJagged1 influences development of hematopoietic precursor cells, and the possibility of ex vivo expansion or maintenance of stem cells was suggested (Jones et al., 1998; Varnum-Finney et al., 1998) .
Abnormalities in the Delta/Serrate-Notch pathway have been reported to be involved in pathogenesis of several diseases. Developmental abnormalities caused by mutations in the Delta/Serrate-Notch pathway in humans and mice have been described. Mutations in hJgged1 cause an autosomal dominant developmental disorder, known as the Alagille syndrome, one of the most common genetic causes of chronic liver diseases in childhood (Li et al., 1997; Oda et al., 1997) . Mutations in hNotch-3 have similarly been causally implicated in a hereditary adult-onset condition causing stroke and dementia known as CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy) (Joutel et al., 1996) . A mutation in Dll3, the other divergent Delta homologue in the mouse, is responsible for a mouse mutant Pudgy with patterning defects during embryogenesis and severe vertebral and rib deformities in the adult mice (Kusumi et al., 1998) . A spontaneous mutation (syndactylism) and targeted disruption of mSerrate-2 (mJagged2) result in abnormal development of limb and T-cells (Jiang et al., 1998; Sidow et al., 1997) . In addition to developmental disorders, it is conceivable that abnormal activation of Delta/Serrate or Notch, under certain circumstances, leads to cell proliferation rather than terminal differentiation, ultimately resulting in neoplasia. The first mammalian gene found for this pathway, a human Notch homologue TAN-1 (hNotch-1), was in fact identified during a study of a t(7;9)(q34;q34.3) reciprocal translocation in acute T lymphoblastic leukemia, resulting in production of an activated form of truncated Notch (Ellisen et al., 1991) . Up-regulation of hNotch-1, hNotch-2, hJagged1 and H-Delta-1 expression has been reported in cervical neoplasms (Gray et al., 1999; Zagouras et al., 1995) . In addition, the int-3 identified as an oncogene activated by insertion of a mouse mammary tumor virus has been found to be a member of the Notch family and designated as mNotch-4 (Jhappan et al., 1992) . H-Delta-1 and mDelta1 have been mapped to human chromosome 6q27 (Gray et al., 1999) and the mouse chromosome 17 tcomplex (Bettenhausen et al., 1995) , respectively. It is clearly of interest to survey whether causal genes for any inherited disorders or cancer of man and the mouse are located at these loci.
